European Investment Bank

Marinomed Biotech AG is a biopharmaceutical company based in Vienna, Austria, specializing in the development of innovative therapies for respiratory and ophthalmological diseases. Founded in 2006, the company operates primarily through two technology platforms: Marinosolv and Carragelose. Marinosolv enables the creation of stable aqueous formulations for poorly soluble compounds, enhancing their bioavailability and therapeutic efficacy, while Carragelose offers antiviral solutions aimed at respiratory viruses. Marinomed's product portfolio includes nasal sprays, throat sprays, and lozenges designed to block viruses and alleviate symptoms associated with conditions such as cough, cold, influenza, and allergic rhinitis. The company collaborates with partners to market its products globally, focusing on improving treatment options for patients with sensitive tissues in the nose and eyes.

Enpal GmbH is a Berlin-based company founded in 2017 that specializes in providing comprehensive renewable energy solutions, primarily through the installation and operation of solar panels for residential electricity generation. The company offers a range of products, including solar panels, batteries, wallboxes, heat pumps, and energy management systems, catering to customers in Germany and Italy. Enpal initially adopted a sales-based model but successfully transitioned to a lease model that requires no upfront payment and includes installation, insurance, and maintenance services. This approach has resulted in significant growth, with over 60,000 solar PV systems installed and revenues exceeding 400 million euros as of 2022. Enpal employs more than 1,000 team members, including over 200 local installer teams, and has opened several satellite offices to enhance customer service across its markets. The company has received numerous awards for its contributions to sustainability and customer service, positioning itself as a leader in the solar PV installation sector in Germany.

Polski Koncern Naftowy Orlen is a prominent energy conglomerate operating primarily in the oil and gas sector. The company refines and distributes oil in Poland, the Czech Republic, Germany, and Lithuania, processing crude oil into various products such as gasoline, diesel, fuel oil, and aviation fuel through its network of refineries. In addition to refining, Orlen produces petrochemicals and chemical feedstock. The company is also involved in exploration and production activities in Poland and Canada. Orlen's extensive logistics infrastructure supports its operations, featuring both surface and underground storage depots, as well as a long-distance pipeline network, which facilitates the distribution of oil products through a widespread network of service stations.

GEWOBA Aktiengesellschaft Wohnen und Bauen is a prominent real estate company based in Bremen, Germany, founded in 1924. The company specializes in residential real estate management, acquisition, construction, urban development, leasing, and brokerage services. In addition to its real estate operations, GEWOBA also oversees the Gewoba Foundation, established in 1999, which focuses on providing commercial and residential rental properties, along with property management and development services. The foundation's assets are managed by a dedicated board of directors, ensuring effective governance and operational oversight.

Vay is a Berlin-based deep technology company that is on track to launch the first driverless, safety-certified, commercial fleet on European public streets. The company aims to revolutionize urban transportation by enabling remote-controlled cars, offering a safer, more efficient solution for ride-hailing and vehicle-sharing services. Vay’s unique approach blends the advantages of self-driving technology with human supervision to ensure safety and adaptability in complex driving environments. Their goal is to reduce urban congestion, cut emissions, and make mobility more sustainable while providing a seamless transportation experience for users.

NVision Imaging Technologies GmbH, founded in 2015 and based in Ulm, Germany, specializes in developing and commercializing innovative imaging and sensing applications grounded in quantum physics. The company has created a platform that polarizes natural metabolites, enabling their use as agents for imaging tumor metabolism through magnetic resonance imaging (MRI). This technology leverages advancements in quantum physics to transform the medical imaging and diagnostics landscape, allowing standard Magnetic Resonance Spectrometers to evaluate human metabolism. As a result, healthcare professionals can conduct advanced cancer diagnostics and monitor treatment responses in real-time, enhancing the precision and effectiveness of cancer care.

Deutsche Glasfaser Holding GmbH, founded in 2012 and based in Borken, Germany, specializes in the planning, construction, and operation of fiber optic networks aimed at rural and suburban areas. As a pioneering provider in the industry, the company focuses on delivering fiber-to-the-home (FTTH) connections to private households, businesses, and public institutions. By collaborating closely with municipalities, Deutsche Glasfaser aims to facilitate nationwide broadband expansion, contributing significantly to Germany's digital progress. The company is recognized for its innovative and cost-efficient approaches to fiber optic deployment, positioning itself as a technology leader in the market. With substantial backing from experienced investors, Deutsche Glasfaser has emerged as one of the strongest providers in Germany's telecommunications landscape.

Protembis GmbH, established in 2017 and based in Aachen, Germany, specializes in the development of innovative surgical equipment, particularly focusing on minimally invasive medical devices. The company's flagship product, the ProtEmbo System, is an intra-aortic filter designed to mitigate the risk of cerebrovascular events during transcatheter aortic valve replacement (TAVR) procedures. This device effectively deflects embolic material generated during these cardiovascular interventions away from the cerebral circulation, thereby reducing the likelihood of brain injury. By enhancing the safety of TAVR, Protembis aims to improve patient outcomes, particularly as this procedure becomes more common among younger and lower-risk individuals. Through its advancements, Protembis is committed to increasing the quality of life for patients while also addressing the broader healthcare costs associated with complications arising from surgical interventions.

Evonik Industries AG, headquartered in Germany, is a global specialty chemicals company. It operates in four major segments: specialty additives, smart materials, nutrition and care, and performance materials. Evonik produces and markets chemicals used in diverse industries, from automotive to pharmaceuticals, offering innovative solutions in areas such as animal nutrition, additives, smart materials, health care, and high-performance polymers. The company is a market leader in approximately 80% of its businesses and has a significant presence in Europe, North America, and Asia. Evonik Venture Capital, its corporate venture arm, invests in startups and venture capital funds with innovative technologies and high growth potential, focusing on areas such as resource efficiency, specialty additives, health & care, and nutrition.

Volvo Car Group, established in 1927, is a global premium car manufacturer headquartered in Gothenburg, Sweden. It produces a range of vehicles including sedans, estates, cross country vehicles, SUVs, and convertibles, renowned for their intuitive Scandinavian design and focus on safety and sustainability. With sales in over 100 countries, Volvo Cars' largest markets are the United States, Sweden, China, Germany, and the UK. The company is committed to sustainable mobility, offering plug-in hybrid and electric cars, and is owned by Zhejiang Geely Holding of China. Volvo Car USA, based in Mahwah, New Jersey, is responsible for the production and sales of Volvo cars in the United States.

VoltStorage GmbH is a German company specializing in the development and production of solar energy storage systems. Based in Olching, Germany, it utilizes eco-friendly vanadium redox flow technology to create power storage devices that allow homeowners to store surplus solar energy generated during the day for use at night. This innovative approach aims to provide renewable energy availability around the clock, contributing to a cleaner and fairer world for future generations. VoltStorage also offers installation and technical support services for its products, which are sold online. The company's commitment to sustainability underscores its mission to enhance the accessibility of renewable energy.

Wingcopter GmbH is a German manufacturer of advanced delivery drones, specializing in unmanned aircraft systems designed for both social and civilian applications. Founded in 2014 and based in Darmstadt, the company focuses on optimizing medical supply chains and last-mile logistics for various sectors, including healthcare, agriculture, forestry, and mining. Its flagship model, the Wingcopter 198, features a patented tilt-rotor mechanism that allows for vertical takeoff and landing while enabling efficient long-distance flight, even under challenging weather conditions. The drones are utilized for delivering essential items such as medicines, vaccines, and food to remote locations, as well as for inspecting public infrastructure. Wingcopter's commitment to improving and saving lives has garnered recognition, including being named a Technology Pioneer by the World Economic Forum in 2020. The company employs a dedicated team of 120 professionals focused on meaningful commercial and humanitarian applications.

AT&S is a European manufacturer of printed circuit boards, specializing in high-end technology. The company provides a diverse array of printed circuit boards tailored to meet specific customer requirements, including double-sided plated-through, multi-layer, high-density interconnection, laser-drilled insulated metallic substrates, flexible, rigid-flex, and semi-flexible options. AT&S serves various core markets, such as mobile devices, automotive, industrial, medical, aviation, and advanced packaging. With a workforce of approximately 7,300 employees, including around 1,200 in Austria, AT&S is headquartered in Leoben, Austria. The company has demonstrated notable financial performance, achieving significant sales revenues in recent years.

Smart Reporting GmbH is a Munich-based company that specializes in providing a digital health solution for structured medical reporting, particularly in the fields of radiology and pathology. Established in 2014, the company offers an online platform that enables radiologists to generate high-quality medical reports through intelligent software that adheres to guideline-compliant criteria. The platform facilitates the creation of report templates, automatic text suggestions, and integration with hospital systems, thereby enhancing the efficiency and quality of medical reporting. Additionally, Smart Reporting provides tools for hospitals and practices to implement reporting standards, optimize templates, and ensure consistent report appearance across various physicians. The company also supports medical registries and clinical studies with solutions for structured reporting, data collection, and multilingual capabilities, all aimed at improving communication and quality assurance in medical documentation.

SiPearl is a French semiconductor company established in 2019 and headquartered in Maisons-Laffitte, Île-de-France. The company specializes in designing high-performance, low-power microprocessors aimed at powering exascale supercomputers. Its flagship product, Rhea, is based on the Arm Neoverse V1 architecture and is set to be commercialized in early 2024. SiPearl's microprocessors are intended for a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, catering to scientific researchers as well as prominent players in the IT, electronics, and automotive industries. The company is committed to producing its microprocessors using advanced manufacturing processes from TSMC, specifically N6 or better. SiPearl also maintains research and development centers across France, Germany, and Spain, aligning its roadmap with the European Union's technological goals.

GeNeuro is a clinical-stage biotechnology company based in Plan-Les-Ouates, Switzerland, specializing in the development of therapeutic drugs for diseases linked to the expression of pathogenic proteins derived from human endogenous retroviruses. The company primarily targets nervous system disorders, including multiple sclerosis and schizophrenia. Its lead product, GNbAC1, is a therapeutic monoclonal antibody aimed at treating multiple sclerosis, while temelimab, another candidate, neutralizes a pathogenic protein associated with the HERV-W family. In addition to its therapeutic developments, GeNeuro also focuses on creating diagnostic tests to measure multiple sclerosis-associated retrovirus-ENV proteins in patients. Founded in 2006, GeNeuro is committed to addressing the underlying causes of neurodegenerative and autoimmune diseases.

numares AG is a German company that specializes in developing and marketing software-based test systems for clinical diagnostics and life science research. Founded in 2004 and headquartered in Regensburg, the company employs nuclear magnetic resonance (NMR) spectroscopy to create diagnostic tests that evaluate metabolomic networks. Its AXINON in vitro diagnostic (IVD) system produces a numeric spectrum that provides valuable insights into patients' disease statuses, assisting physicians in their evaluations. Utilizing magnetic group signaling (MGS) technology, numares focuses on diagnostics in areas such as cardiovascular diseases, nephrology, oncology, and neurology. The company is recognized as a leader in commercial NMR analytics in Europe, offering a comprehensive range of NMR-analytic services that are fast, cost-efficient, and reliable, enabling doctors to interpret complex metabolic patterns from blood and urine samples effectively.

Siltronic AG specializes in the development, production, and marketing of semiconductor wafers, a critical component in the electronics industry. Established in 1968 and headquartered in Munich, Germany, the company operates a global network of advanced production facilities in Asia, Europe, and the United States, including state-of-the-art plants for 200 mm and 300 mm wafers in Singapore. Siltronic's product offerings include polished wafers, epitaxial wafers, annealed wafers, floatzone wafers, power products, and ultimate silicon. With a workforce of approximately 3,600 employees, the company serves various geographic markets, including Germany, the broader European region, the United States, Taiwan, mainland China, South Korea, and other parts of Asia.

SpinDiag GmbH is a German company specializing in the development of automated point-of-care systems for the rapid detection of infectious diseases. Founded in 2016 and headquartered in Freiburg, SpinDiag manufactures a compact, user-friendly centrifugal-microfluidic test system that enables healthcare professionals to detect drug-resistant bacteria and other pathogens directly from patient samples. Its flagship product, which includes an automated SARS-CoV-2 test, allows for the screening of up to 25 antibiotic resistances upon patient admission, effectively preventing the spread of infections by isolating affected individuals. The system streamlines the testing process with a fully automated workflow that can be operated by nursing staff, providing laboratory-grade PCR results from standard swab samples without the need for additional sample collection. By integrating this technology into everyday clinical practice, SpinDiag enhances diagnostic efficiency and safety in healthcare settings.

Aquila Capital is a private investment firm based in Hamburg, Germany, founded in 2001. It specializes in providing institutional investors, pension funds, foundations, and individuals with alternative investment solutions across real assets, financial markets, and private equity. The firm employs a multi-disciplinary investment approach, leveraging a team of dedicated specialists to manage a diverse range of investments, including hedge funds, private equity fund of funds, real estate, and infrastructure projects. Aquila Capital emphasizes strong operational frameworks and corporate governance to enhance its investment management capabilities. The firm operates additional offices in Frankfurt, Munich, and Vienna, and aims to identify and manage attractive investment opportunities for its clients through a solution-oriented approach that encompasses strategy development, implementation, and asset management.

Blickfeld GmbH, established in 2016 and based in Munich, Germany, specializes in the production of LiDAR sensors and associated software. These sensors use near-infrared light to detect and map objects, enabling autonomous vehicles to perceive their surroundings. The company's patented silicon MEMS mirrors and commercial off-the-shelf components allow for low-cost mass production, making LiDAR technology more accessible to the automotive industry. Additionally, Blickfeld's object detection and mapping software processes sensor data, facilitating applications such as city planning, real-time mapping, and usage pattern analysis. The company serves various sectors, including automotive, transportation, industrial, and robotics.

InstaFreight GmbH, founded in 2016 and based in Berlin, Germany, specializes in online freight forwarding services for B2B customers. The company aims to simplify the booking and processing of freight transport, making it fast and straightforward. By focusing on reliability, quality, efficiency, and transparency, InstaFreight seeks to position itself as Europe's leading digital forwarding company. It offers innovative solutions that enhance supply chain management and provide clear visibility for both customers and carriers, ultimately reducing complexity in logistics operations.

TRUMPF, a German high-technology company, is a global leader in manufacturing sheet metal fabrication machinery, industrial lasers, and medical technologies. It offers a wide range of production solutions, including laser cutting, welding, and marking systems, as well as punching and additive production equipment. TRUMPF Venture, established in 2016, is the company's corporate venture capital arm, investing in early-stage startups that operate in areas complementary or adjacent to TRUMPF's core business, such as advanced photonics and smart factories. The venture capital arm seeks innovative technologies and business models, and provides funded startups with access to its extensive network, deep domain expertise, and support for scaling and market entry. TRUMPF, as an independent, family-owned company, focuses on long-term strategies and continuous innovation to drive digital connectivity in manufacturing.

DyeMansion GmbH, established in Munich, Germany in 2013, specializes in post-processing and coloring of 3D-printed laser sintered parts. The company offers high-volume finishing systems that transform raw, 3D-printed parts into high-value consumer and industrial products, such as eyewear, automotive components, and medical devices. DyeMansion works with major 3D printing systems like EOS, HP, and 3D Systems, enabling precision coloring and finish to exact specifications. With over 400 customers, including leading global manufacturers, DyeMansion has become the global leader in additive manufacturing finishing systems for 3D-printed polymer parts.

Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels using a proprietary polymer-based technology. Xeltis' RestoreX platform enables the body's natural healing system to develop tissue that replaces the implant, forming a new functional valve or vessel. The company's restorative devices include implantable small diameter blood vessels for hemodialysis and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. Xeltis has raised funding from various venture capital firms and European institutions, including a €30 million round in 2021.

Ørsted is a Danish company specializing in the development and maintenance of offshore and onshore renewable energy farms, energy storage facilities, and bioenergy plants. Formerly known as DONG Energy, Ørsted has undergone a significant transformation over the past decade, committing to a vision of a world powered entirely by green energy. The company has dramatically reduced its coal consumption by 73% and aims to completely phase out coal by 2023. As a global leader in offshore wind, Ørsted holds a 25% market share, providing energy to approximately 9.5 million people. By the end of 2023, Ørsted operated 8.9 gigawatts of offshore wind capacity, with the United Kingdom being its largest market, followed by Germany and Denmark. The company is also expanding its presence outside Europe with projects in Taiwan and the United States, where it operates 4.8 gigawatts of onshore wind and solar assets. In addition to its renewable initiatives, Ørsted still engages in traditional utilities, including conventional power plants.

IDnow is a Munich-based company that specializes in identity verification technologies through its Identity-as-a-Service platform. Founded in 2014, IDnow employs advanced machine-learning techniques to offer real-time identity verification and electronic signing solutions, ensuring legal security and high data protection standards across Europe. Its services are tailored for business clients, including banks, telecommunications companies, and fintech firms, facilitating online customer identification and contract conclusion without the need for additional hardware. The platform allows users to verify their identities conveniently using smartphones, tablets, or webcams. IDnow's client roster features prominent organizations such as Commerzbank, UBS, Sixt neuwagen, Telefónica, and N26, highlighting its role as a key player in the identity verification sector.

Robart is an Austrian high-tech start-up established in 2009, dedicated to developing autonomous mobile robots for both consumer and industrial applications using its proprietary Artificial Intelligence Control Unit (AICU) technology. The company aims to democratize robotics with the vision of integrating robots into everyday life, focusing on creating low-cost solutions that empower industry leaders to innovate in the robotic product space. Robart's robots are designed to enhance user experience by detecting obstacles and navigating complex home environments, offering functionalities such as smart cleaning and mopping. By addressing current limitations in consumer robotics, Robart emphasizes precise task execution, robust functionality, and intuitive user interaction, positioning itself at the forefront of next-generation intelligent robotics.

Magazino GmbH is a Munich-based company that specializes in the development and production of mobile robots tailored for the storage and intralogistics sectors. Founded in 2014, the company focuses on creating perception-controlled robots capable of identifying, grasping, and placing individual items precisely, utilizing advanced 2D and 3D camera technology. Their product offerings include mobile pick-and-place robots designed for e-commerce warehouses, which operate collaboratively in swarms, and are supported by their proprietary operating systems, ACROS and App ARC. These technologies streamline the automation of daily operations for various clients, including mail-order companies, warehousing facilities, production lines, and pharmacies. Magazino aims to revolutionize the logistics industry by creating intelligent robots that enhance operational efficiency and contribute to the future of robotics.

NavVis GmbH, established in 2013 and headquartered in Munich, Germany, specializes in indoor spatial intelligence solutions. The company offers the NavVis M6, a mobile mapping system that captures 360° immersive imagery and point clouds for large-scale scanning projects. NavVis IndoorViewer, their digital twin software, combines point clouds with highly detailed 360° images, enabling stakeholders to explore and interact with scanned spaces. Their solutions cater to various industries, including automotive, construction, real estate, and insurance, serving applications such as CAD/BIM modeling, factory planning, and indoor mapping. NavVis' technology bridges the gap between the physical and digital worlds, providing high-quality data with survey-grade accuracy at speed and scale, thereby driving operational efficiencies and informed decision-making.

CureVac is a clinical-stage biopharmaceutical company based in Germany, established in 2000, that specializes in developing vaccines and therapies utilizing messenger ribonucleic acid (mRNA). The company focuses on both prophylactic and therapeutic applications of mRNA, enabling the human body to produce proteins that combat various diseases. CureVac's innovative pipeline includes mRNA-based cancer immunotherapies, such as CV9104, which is in Phase IIb development for prostate cancer, as well as RNActive vaccines against infectious diseases and RNArt molecular therapies designed to stimulate the production of therapeutic proteins. Additionally, the company has collaborated with GSK to advance second-generation vaccines for seasonal influenza and COVID-19, alongside an avian influenza vaccine, while also exploring mRNA therapies for oncology and other conditions affecting the liver and eyes.

BioNTech is a Germany-based biotechnology company that specializes in developing innovative immunotherapies for cancer and other serious diseases, as well as vaccines for infectious diseases, including COVID-19. The company’s oncology pipeline includes a range of drug classes, such as mRNA-based drugs that encode antigens and neoantigens, cell therapies, bispecific antibodies, and antibody-drug conjugates. BioNTech has established partnerships with several major pharmaceutical companies, enhancing its research and development capabilities. Its COVID-19 vaccine, Comirnaty, represents its first commercialized product, demonstrating the company's commitment to addressing urgent health challenges through advanced therapeutic approaches.

Telefónica Deutschland is a prominent integrated telecommunications provider based in Munich, Germany, offering a wide range of mobile and fixed services for both private and business customers. The company manages approximately 49.6 million customer lines, with over 45 million in the mobile segment alone. Telefónica Deutschland's offerings include postpaid and prepaid mobile products, mobile data services utilizing GPRS, UMTS, and LTE technologies, as well as DSL fixed network telephony and high-speed internet services. Following its integration of E-Plus, the company is committed to digitalizing its business model while enhancing customer experience. With aspirations to become the preferred partner in the German mobile service market, Telefónica Deutschland aims to simplify and improve its customers' lives, providing them with mobile freedom in an increasingly digital world.

BioNTech is a Germany-based biotechnology company that specializes in developing innovative immunotherapies for cancer and other serious diseases, as well as vaccines for infectious diseases, including COVID-19. The company’s oncology pipeline includes a range of drug classes, such as mRNA-based drugs that encode antigens and neoantigens, cell therapies, bispecific antibodies, and antibody-drug conjugates. BioNTech has established partnerships with several major pharmaceutical companies, enhancing its research and development capabilities. Its COVID-19 vaccine, Comirnaty, represents its first commercialized product, demonstrating the company's commitment to addressing urgent health challenges through advanced therapeutic approaches.

Bitmovin Inc is a multimedia company specializing in online streaming solutions and video infrastructure for over-the-top (OTT) services. Founded in 2012 and headquartered in San Francisco, California, with an additional office in Klagenfurt, Austria, Bitmovin develops a range of products including a cloud-based transcoding-as-a-service platform, optimized MPEG-DASH clients, and an encoding API for real-time content encoding. Their offerings also include a video player that enhances viewer experience across various streaming devices and analytics tools designed to boost viewer engagement through actionable data. Bitmovin's roots trace back to the Alpen-Adria-University Klagenfurt, from which many of its experts originate, and the company continues to engage in research and standardization in multimedia, particularly within the ISO/IEC MPEG framework. With a focus on delivering high-quality streaming experiences, Bitmovin caters to online media companies globally, helping them optimize video quality and reduce loading times for their audiences.

FAZUA GmbH specializes in the development and manufacturing of e-bike drive systems, aiming to enhance cycling mobility while maintaining the natural feel of traditional non-motorized biking. Founded in 2013 and headquartered in Ottobrunn, Germany, the company offers the FAZUA evation drive system, which includes a motor, gearbox, battery, and power electronics. This innovative system allows for seamless switching between motorized assistance and traditional pedaling, catering to sportive cycling demands. The design enables easy removal and replacement of the drive system from the bike's downtube, allowing manufacturers to create sleek and integrated bike frames that accommodate the drive pack without compromising aesthetics.

FlixBus, operated by FlixMobility, is a notable provider of intercity travel, focusing on affordable, convenient, and environmentally-friendly transportation solutions. Since its inception in 2013, the company has established Europe's largest long-distance bus network and introduced green long-distance trains in 2018, alongside a pilot for all-electric buses in Germany and France. The platform offers travelers a sustainable alternative to private transportation, featuring amenities such as free WiFi, flexible online booking, and innovative ticketing systems. FlixBus also expanded its services to the United States in 2018, bringing its unique travel model to a broader audience. By collaborating with regional bus partners and private train companies, FlixMobility combines technological innovation with traditional transportation expertise, positioning itself as a leader in the evolving mobility landscape. As a result, FlixBus has transformed the travel experience for over 100 million people across Europe and the United States while contributing to job creation in the mobility sector.

Curetis AG is a Germany-based company that specializes in developing molecular diagnostics solutions for infectious diseases. Founded in 2015 and now operating as a subsidiary of OpGen, Inc., Curetis focuses on the detection of pathogens and antibiotic resistance markers. The company offers a rapid diagnostic platform that enables multiparameter testing of various analytes in a single run, providing comprehensive panels for detecting a wide range of pathogens and resistance genes. This innovative approach aims to improve patient outcomes by delivering early, actionable information to healthcare providers, particularly in the context of severe bacterial infections. Curetis's technology not only addresses current healthcare challenges but also presents opportunities for future expansions into other clinical applications beyond infectious diseases.

tado° GmbH is a technology company based in Munich, Germany, with an additional office in London, United Kingdom. Founded in 2010, it specializes in developing and marketing innovative home climate control systems that enhance the efficiency of heating and cooling in residential and small business environments. The company's products integrate a hardware-software combination that leverages real-time data on resident behavior, weather forecasts, and building characteristics to optimize climate management. tado° sells its solutions through both retail outlets and online platforms, effectively bringing Internet of Things technology to the cleantech market.

Nokia, a Finnish multinational, specializes in telecommunications infrastructure and services. It offers hardware and software for building wireless and fixed-line networks, enabling connectivity for people, machines, and devices worldwide. The company operates in four segments: Mobile Networks (equipment and services for public wireless networks), Network Infrastructure (fixed networks, IP, optical, and submarine networks), Cloud and Network Services (enterprise as-a-service platforms), and Patent Business (technology licensing). Nokia's products and services are used by telecom carriers, industries, and the public sector, providing insights, analytics, automation, and cybersecurity solutions. With a significant research division and global presence, Nokia employs around 100,000 people across over 150 countries, with major manufacturing sites in Finland, India, and China.

Indivumed was founded in Hamburg, Germany in 2002 with one main driver – the individualization of cancer therapy through the generation, characterization, and analysis of biologic samples from human cancer patients. Since then, the company has expanded globally, with a subsidiary in the USA, partnerships with leading cancer clinics in Europe, the US and Asia and more than 50 oncology practices located in Germany, and, finally, more than 100 biopharma industry partners – and a global reputation for product and service quality.

Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

medneo GmbH is a Berlin-based company that specializes in providing imaging diagnostic services within the healthcare sector. It operates under a "radiology as a service" model, delivering medical images directly to clinicians, hospitals, and research institutes rather than selling imaging equipment. By utilizing advanced diagnostic platforms and a teleradiology network, medneo enhances the efficiency and effectiveness of medical imaging processes. The company aims to improve the utilization of imaging equipment, deliver high-quality images, and ensure timely access to radiology services, thereby reducing patient wait times and overall costs for healthcare providers. Through its innovative approach, medneo contributes to optimizing treatment procedures in the medical field.